Role of type 3 deiodinase in cancer

By Dentice Monica   Ambrosio Raffaele   Salvatore Domenico  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 11, 2009-11 ,pp. : 1363-1373

Informa Healthcare

Access to resources Recommend Favorite

EMP3 as a candidate tumor suppressor gene for solid tumors

By Fumoto Shoichi   Tanimoto Keiji   Hiyama Eiso   Noguchi Tsuyoshi   Nishiyama Masahiko   Hiyama Keiko  

Expert Opinion on Therapeutic Targets, Vol. 13, Iss. 7, 2009-07 ,pp. : 811-822

Informa Healthcare

Access to resources Recommend Favorite

Dasatinib in solid tumors

By Kim Lori C   Rix Uwe   Haura Eric B  

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 3, 2010-03 ,pp. : 415-425

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

By Steeghs Neeltje   Gelderblom Hans   Wessels Judith   Eskens Ferry   Bont Natasja   Nortier Johan   Guchelaar Henk-Jan  

Investigational New Drugs, Vol. 29, Iss. 1, 2011-02 ,pp. : 137-143

Springer Publishing Company

Access to resources Recommend Favorite

Drug Delivery and Transport to Solid Tumors

By Jang Seong Hoon   Wientjes M. Guillaume   Lu Dan   Au Jessie L.-S.  

Pharmaceutical Research, Vol. 20, Iss. 9, 2003-09 ,pp. : 1337-1350

Springer Publishing Company

Access to resources Recommend Favorite